Fibrillin-1 Deficiency Perturbs Aortic Cholinergic Relaxation and Adrenergic Contraction in a Mouse Model of Early

Anna Cantalupo1,2, Keiichi Asano1, Sergey Dikalov3

  • 1Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

PubMed
Abstract

Insights

Nitric oxide (NO) signaling is impaired in Marfan syndrome (MFS) mice, leading to reduced aortic relaxation and increased contractility. This endothelial dysfunction contributes to thoracic aortic aneurysm (TAA) development.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Genetics

Background:

  • The role of nitric oxide (NO) in thoracic aortic aneurysm (TAA) development within Marfan syndrome (MFS) remains incompletely understood.
  • This study investigates NO signaling pathways in MFS, focusing on early-onset, progressive disease in a mouse model.

Purpose of the Study:

  • To characterize the vasomotor function in MFS mice.
  • To determine the relationship between NO-generating enzyme activity and TAA pathogenesis in MFS.

Main Methods:

  • Wire myography was employed to assess aortic ring function.
  • Immunoblotting, NO, and superoxide level measurements were conducted.
  • Activity of endothelial (eNOS) and inducible (iNOS) NO synthase was compared between MFS and wild-type mice.

Main Results:

  • MFS mice exhibited reduced acetylcholine-induced relaxation and increased phenylephrine-induced contractility.
  • Abnormalities included decreased eNOS phosphorylation at Ser1177, reduced NO production, and elevated superoxide levels.
  • Aortic hypercontractility was linked to alpha1-adrenoceptor upregulation, with endothelial dysfunction playing a significant role.

Conclusions:

  • Impaired endothelial nitric oxide synthase (eNOS) signaling disrupts normal aortic relaxation and contraction.
  • This disruption contributes to the development of dissecting thoracic aortic aneurysms in Marfan syndrome.